Having taken Labour Day off, I present a double edition of biotech highlights:
Double Money:
- Genome BC and Genome Canada put $3.4 million into a grape and wine genomics project [1] that will try to bring molecular techniques to bear on winemaking. And…
- The Federal Economic Development Agency for Southern Ontario (FedDev Ontario) is providing $50 million to BDC [2] for direct investments in “early-stage firms in Southern Ontario” and for investments in VC funds “focused on Ontario-based opportunities.”
Double Caution:
- An article in the New York Times called direct-to-consumer genetic testing “fraught with potential dangers.” [3] And…
- The FDA revised its warning letters webpage [4] to make the most recent warning letters easier to find.
Double Endings:
- BioMS had a change of luck and terminated its development agreement with Eli Lilly [5]. And…
- MDS is selling its Analytical Technologies Business [6] and plans to sell its Pharma Services Business next.
And to end on a good note… Double Stimulus:
- Despite generally dismal U.S. job numbers, extra funding for the NIH helped the health care and education sectors add about 52,000 jobs in August [7]. And…
- A study by a group at the McLaughlin-Rotman Centre for Global Health [8] aims to stimulate more Canadian collaborations with developing country partners [9].
To find out more, check out our “double your knowledge or your money back” guarantee at The Cross-Border Biotech Blog [10].